Dose Adjustment Patterns in the Open-Label Extension Arms of Three Phase 3 Trials of Certolizumab Pegol in Psoriasis: CIMPASI-1, CIMPASI-2, and CIMPACT
作者
Andrew Blauvelt,A.B. Gottlieb,Frederik L. P. Fierens,Fiona Brock,Susanne Wiegratz,Howard L. Sofen
出处
期刊:Skin [National Society for Cutaneous Medicine] 日期:2020-10-27卷期号:4 (6): s85-s85